Sign in

Private company

ATRION CORP

ATRION CORP is an American surgical and medical instruments and apparatus company.1 It is headquartered in Allen, Texas.1

Last updated Oct 21, 2026.

Overview

  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersAllen, Texas1
  • Incorporated inDE2
  • Business addressOne Allentown Parkway, Allen, Tx 750022
  • Filer categoryNon-accelerated filer2

See how the biggest companies compare on our leaderboards

Atrion Corporation and its subsidiaries (”we,” “our,” “us,” “Atrion,” or the “Company”) develop and manufacture products, primarily for medical applications. Our medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

0.0%Gross margin5
0.0%Operating margin5
11.5%Net margin5
-7.7%Revenue growth, 20235
7991.7%Return on equity5
-$2.3KFree cash flow5

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue0¢$106.9K
  • Research and development0¢$6.7K
  • Other costs87¢$146.8M
  • Interest0¢$149
  • Income tax2¢$3.0M
  • Profit11¢$19.4M

Out of $169.3M in revenue.5

Where each dollar of operating cash went, fiscal 2023

  • Capital spending57¢$22.3K
  • Dividends paid39¢$15.3K
  • Share buybacks4¢$1.7K

Out of $20.0K of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.5

Financial statements

Revenue67895$169.3M in 2023+16% since 2017
0$50.0M$100.0M$150.0M$200.0M2017: $146.6M$146.6M20172018: $152.4M$152.4M2018+4%2019: $155.1M$155.1M2019+2%2020: $147.6M$147.6M2020−5%2021: $165.0M$165.0M2021+12%2022: $183.5M$183.5M2022+11%2023: $169.3M$169.3M2023−8%
Gross profit67895$62.4K in 2023−100% since 2017
0$20.0M$40.0M$60.0M$80.0M2017: $70.8M$70.8M20172018: $71.8M$71.8M2018+1%2019: $70.7M$70.7M2019−2%2020: $66.2M$66.2M2020−6%2021: $69.4K$69.4K2021−100%2022: $75.9K$75.9K2022+9%2023: $62.4K$62.4K2023−18%
Operating income67895$22.6K in 2023−100% since 2017
0$20.0M$40.0M$60.0M2017: $41.3M$41.3M20172018: $41.7M$41.7M2018+1%2019: $40.5M$40.5M2019−3%2020: $35.7M$35.7M2020−12%2021: $36.0K$36.0K2021−100%2022: $39.7K$39.7K2022+10%2023: $22.6K$22.6K2023−43%
Net income67895$19.4M in 2023−47% since 2017
0$10.0M$20.0M$30.0M$40.0M2017: $36.6M$36.6M20172018: $34.3M$34.3M2018−6%2019: $36.8M$36.8M2019+7%2020: $32.1M$32.1M2020−13%2021: $33.1M$33.1M2021+3%2022: $35.0M$35.0M2022+6%2023: $19.4M$19.4M2023−45%
Fiscal year2017201820192020202120222023
Revenue$146.6M6$152.4M7$155.1M8$147.6M9$165.0M5$183.5M5$169.3M5
Cost of revenue$75.8M6$80.7M6$84.4M6$81.4M9$95.6K5$107.6K5$106.9K5
Gross profit$70.8M6$71.8M7$70.7M8$66.2M9$69.4K5$75.9K5$62.4K5
Research and development$5.8M6$5.5M7$5.0M8$5.6M9$5.7K5$5.5K5$6.7K5
Operating expenses$33.3K5$36.2K5$39.8K5
Operating income$41.3M6$41.7M7$40.5M8$35.7M9$36.0K5$39.7K5$22.6K5
Interest$05$05$1495
Income before tax$38.4K5$40.6K5$22.4K5
Income tax$5.7M6$7.8M7$6.4M8$6.4M9-$5.4M5-$5.6M5-$3.0M5
Net income$36.6M6$34.3M7$36.8M8$32.1M9$33.1M5$35.0M5$19.4M5
Earnings per share$19.826$18.497$19.828$17.499$18.225$19.595$11.025
Earnings per share (diluted)$19.716$18.447$19.738$17.449$18.185$19.565$11.025
Shares (weighted, basic)1.8M shares51.8M shares51.8M shares5
Shares (weighted, diluted)1.8M shares51.8M shares51.8M shares5

Compare ATRION CORP with another company

Corporate structure

ATRION CORP sits at the top of its group. 6 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of ATRION CORP

  • ATRION CORP Allen, Texas
    • AlaTenn Pipeline Company LLC Subsidiary · Alabama, United States
    • Atrion Leasing Company LLC Subsidiary · Alabama, United States
    • Atrion Medical Products, Inc. Subsidiary · Delaware, United States
    • Halkey-Roberts Corporation Subsidiary · Delaware, United States
    • Quest Medical, Inc. Subsidiary · Texas, United States

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What ATRION CORP reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$286.4M5 Dec 31, 2023$270.6M5 Dec 31, 2022+5.8%
Accumulated depreciation$161.1K5 Dec 31, 2023$146.9K5 Dec 31, 2022+9.7%
Property and equipment, net$125.3K5 Dec 31, 2023$123.8K5 Dec 31, 2022+1.3%
Finance-lease assets$206.0K5 Dec 31, 2023$683.0K9 Dec 31, 2022−69.8%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$3.6M5 Dec 31, 2023$4.7M5 Dec 31, 2022−24.6%
Marketable securities, current$2.7M5 Dec 31, 2023$21.2M5 Dec 31, 2022−87.3%
Long-term investments$8.2M5 Dec 31, 2023$8.7M5 Dec 31, 2022−5.8%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$9.7K5 Dec 31, 2023$9.7K5 Dec 31, 20220%
Intangible assets, net (excluding goodwill)$1.2M9 Dec 31, 2022$1.3M9 Dec 31, 2021−9.0%
Accumulated amortization$12.8M5 Dec 31, 2023$12.7M5 Dec 31, 2022+0.9%
Finite-lived intangibles, net$1.1K5 Dec 31, 2023$1.2K5 Dec 31, 2022−9.5%

Inventory

ItemLatestA year beforeChange
Inventory, total$82.3M5 Dec 31, 2023$65.8M5 Dec 31, 2022+25.1%
Raw materials$37.8M5 Dec 31, 2023$33.3M5 Dec 31, 2022+13.3%
Work in process$17.5M5 Dec 31, 2023$13.6M5 Dec 31, 2022+28.2%
Finished goods$27.1M5 Dec 31, 2023$18.8M5 Dec 31, 2022+43.7%

Leadership

Who has led ATRION CORP, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Emile A. Battat2006–2010
  2. David A. Battat2012–2024

Chair

  1. Emile A. Battat2006–2023

President

  1. Emile A. Battat2006–2007
  2. David A. Battat2007–2024

Chief financial officer

  1. Jeffery Strickland2006–2023
  2. Cindy Ferguson2023–2024

Chief operating officer

  1. David A. Battat2007–2010
2010201520202025
Board members and other officers (8)

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • AlaTenn Pipeline Company LLC Alabama3
  • Atrion Leasing Company LLC Alabama3
  • Atrion Medical Products, Inc. Delaware3
  • Halkey-Roberts Corporation Delaware3
  • Quest Medical, Inc. Texas3

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • ALATENN RESOURCES INCNov 14, 1995 to Mar 18, 19962

Timeline

  1. Aug 21, 20248-K Ended a material agreement; Completed an acquisition or sale; Listing notice or transfer29
  2. Aug 20, 20248-K Shareholder vote30
  3. Aug 9, 20248-K Results of operations31
  4. Aug 9, 20248-K Other events32
  5. May 29, 20248-K Entered a material agreement33
  6. May 28, 20248-K Regulation FD disclosure34
  7. May 24, 20248-K Executive or director change; Bylaws or fiscal year changed; Shareholder vote35
  8. May 10, 20248-K Results of operations36
  9. Feb 29, 20248-K Results of operations37
  10. Dec 28, 20238-K Entered a material agreement; New debt or obligation; Executive or director change38
  11. Nov 7, 20238-K Results of operations39
  12. Sep 20, 20238-K Executive or director change; Regulation FD disclosure40
  13. Feb 16, 2012New chief executive David A. Battat becomes CEO16
  14. Aug 9, 2006New chief executive Emile A. Battat becomes CEO17

Calendar

When it reported results

  1. Aug 9, 2024Reported quarterly or annual results31
  2. May 10, 2024Reported quarterly or annual results36
  3. Feb 29, 2024Reported quarterly or annual results37
  4. Nov 7, 2023Reported quarterly or annual results39
  5. Aug 8, 2023Reported quarterly or annual results41
  6. May 8, 2023Reported quarterly or annual results42
  7. Feb 27, 2023Reported quarterly or annual results43
  8. Nov 8, 2022Reported quarterly or annual results44

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

151 filings to the SEC since October 2021: 3 annual reports, 10 quarterly reports, 26 major events, 61 insider forms, 27 large holders, 24 other. The latest 20:

  1. Nov 14, 2024SC 13G/A EDGAR
  2. Sep 9, 2024SC 13G/A EDGAR
  3. Sep 3, 202415-12G EDGAR
  4. Aug 22, 2024SC 13D/A EDGAR
  5. Aug 22, 2024SC 13D/A EDGAR
  6. Aug 22, 2024SC 13D/A EDGAR
  7. Aug 22, 2024SC 13D/A EDGAR
  8. Aug 21, 20244 PRIMARY DOCUMENT EDGAR
  9. Aug 21, 20244 PRIMARY DOCUMENT EDGAR
  10. Aug 21, 20244 PRIMARY DOCUMENT EDGAR
  11. Aug 21, 20244 PRIMARY DOCUMENT EDGAR
  12. Aug 21, 20244 PRIMARY DOCUMENT EDGAR
  13. Aug 21, 202425-NSE EDGAR
  14. Aug 21, 20244 PRIMARY DOCUMENT EDGAR
  15. Aug 21, 2024SC 13D/A EDGAR
  16. Aug 21, 2024S-8 POS EDGAR
  17. Aug 21, 2024S-8 POS EDGAR
  18. Aug 21, 2024S-8 POS EDGAR
  19. Aug 21, 2024S-8 POS EDGAR
  20. Aug 21, 2024S-8 POS EDGAR

The 151 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

6 open-market trades by officers, directors and large owners since October 2021: 3 buys and 3 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Dec 1, 2023Athey Preston GDirectorBuy300$319.68$95.9KForm 4
Nov 16, 2023Battat David APresident & CEOBuy300$300.00$90.0KForm 4
Aug 15, 2023Athey Preston GDirectorBuy200$523.35$104.7KForm 4
Oct 26, 2022STRICKLAND JEFFERYOfficer/ CFOSale1,000$675.00$675.0KForm 4
Dec 20, 2021BATTAT EMILE ADirectorSale3$713.00$2.1KForm 4
Dec 14, 2021BATTAT EMILE ADirectorSale261$683.45$178.4KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How ATRION CORP is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARATRION CORP1
  • CIK0000701288
  • Employer ID (EIN)63-08218191
  • Filer statusNon-accelerated filer1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business addressOne Allentown Parkway, Allen, TX 750021
  • Phone97239098001
  • Shares outstanding1,759,954 as of Jul 26, 202411
  • Public float$767.0M as of Jun 30, 20235
  • On EDGAR sinceFeb 14, 19951
  • Filings859 in all: 4 (295), 8-K (141), 10-Q (89), SC 13G/A (77), DEF 14A (30), 10-K (25), DEFA14A (21), SC 13G (17)1
    All 45 form types

    4/A (16), ARS (16), 5 (14), SC 13D/A (11), SD (11), S-8 POS (10), S-8 (9), SC TO-I/A (7), 3 (6), SC 13D (6), SC 13E4/A (6), 10-K405 (5), 8-K/A (5), UPLOAD (5), CORRESP (4), PRE 14A (4), PREC14A (3), SC 13E4 (3), 10-K/A (2), SC TO-C (2), SC TO-I (2), U-3A-2 (2), 10-C (1), 10-K405/A (1), 10-Q/A (1), 144 (1), 15-12G (1), 25-NSE (1), 8-A12B (1), AW (1), DEFM14A (1), DEFS14A (1), DFAN14A (1), POS AM (1), PREM14A (1), PRES14A (1), U-3A-2/A (1)

  • Latest filingsAnnual report (10-K) Feb 29, 2024
    Quarterly report (10-Q) Aug 9, 2024
    Proxy statement (DEF 14A) Apr 9, 2024
    Latest 8-K (8-K) Aug 21, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
    SEC EDGAROther events
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55